Overview

The Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic study aims to determine if cognitive behavioral therapy (CBT) can prevent insomnia or improve mental health outcomes during the COVID-19 pandemic.

Study Information 

50 participants with sleep troubles who also have a history of depression and are at higher risk for severe COVID-19 will receive either immediate cognitive behavioral therapy for insomnia or a waitlist of 7 months. The waitlist group will receive CBT 7 months after being assigned to their category.

At baseline, quality of life, sleep disruption, suicidal ideation and neuropsychiatric symptoms will be recorded and a second time at the end of the study, by online surveys and clinical interviews. The same parameters will be assessed at subsequent follow-up appointments at 3, 7, and 13 months. Anxiety and depression and sleep disturbance will be recorded at the end of every week to determine weekly changes. 

Inclusion Criteria

• Aged 18 years or older
• Has internet access
• Has self-reported sleep complaints beginning after March 1 2020 or the start of the COVID-19 pandemic
• Lives in the United States

Exclusion Criteria

• Has high risk suicidal ideation 
• Takes medication for sleep problems and is unwilling to discontinue use for more than one week prior to the start of data collection
• History of bipolar disorder or psychosis
• Has substance abuse or dependance
• Cannot provide written and informed consent 
• Illiterate in English
• Has other mental health disorders that are treated in an unstable manner through medication
• Severe vision, hearing or motor impairment
• Inability to follow study protocols
• Works a rotating shift overlapping with 2400h

Locations

Stanford University

Palo Alto, California, United States

Sponsors / Collaborators

Stanford University